NeurATRIS/EATRIS neuroscience webinar series: preclinical models with Celphedia

Titre:
NeurATRIS/EATRIS neuroscience webinar series: preclinical models with Celphedia
Date:
Mer, 17. avril 2019
Catégorie:
Evénements

Description

We are pleased to announce that EATRIS and NeurATRIS are launching a second series of webinars on neurodegenerative diseases in April-May of this year. The series will cover the usage of biological and technological tools such as preclinical models or ultra high field MRI in neurodegenerative diseases and their potential application in translational medicine. These webinars will be brought to you by experts in the field, each time in collaboration with a specialized European Research Infrastructure.

All webinars are free of charge. The neuroimaging webinars include an audience Q&A session during which attendees can ask questions at the end of the lecture. Please note that all webinars will be recorded and available for later viewing.

The first session of this series will take place on April 17th at 11:00 AM and will be jointly animated by EATRIS, NeurATRIS and Celphedia.

 

SESSION 4: April 17TH 11.00 – 12.00 (CET)

IN VIVO PRECLINICAL MODELS FOR THE STUDY OF NEURODEGENERATIVE DISEASES by Dr. Romina Aron Badin (NeurATRIS) and Dr. Marie-Christine Birling (Celphedia)

Animal models are an indispensable research tool to understand, assess and treat neurodegenerative diseases in the preclinical setting. In this webinar, the speakers will highlight the contributions of discovery and experimentation in rodents and non-human primate (NHP) models to understand health and disease in humans and to preclinical drug development. The speakers will then focus on how to generate NHP models for neurodegenerative diseases and how to characterize them, using the example of a preclinical model of Tauopathy (viral overexpression) and the validation of a new gene therapy strategy for Parkinson’s disease (MPTP model).

For more information and registration: https://eatris.eu/events/webinar-vivo-preclinical-models-neurodegenerative-diseases/